250 related articles for article (PubMed ID: 28558381)
1. Aldolase B Overexpression is Associated with Poor Prognosis and Promotes Tumor Progression by Epithelial-Mesenchymal Transition in Colorectal Adenocarcinoma.
Li Q; Li Y; Xu J; Wang S; Xu Y; Li X; Cai S
Cell Physiol Biochem; 2017; 42(1):397-406. PubMed ID: 28558381
[TBL] [Abstract][Full Text] [Related]
2. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
Jiang Z; Wang X; Li J; Yang H; Lin X
J Cell Mol Med; 2018 Sep; 22(9):4377-4386. PubMed ID: 29992789
[TBL] [Abstract][Full Text] [Related]
3. Aldolase A overexpression is associated with poor prognosis and promotes tumor progression by the epithelial-mesenchymal transition in colon cancer.
Ye F; Chen Y; Xia L; Lian J; Yang S
Biochem Biophys Res Commun; 2018 Mar; 497(2):639-645. PubMed ID: 29453983
[TBL] [Abstract][Full Text] [Related]
4. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
Li CF; Li YC; Wang Y; Sun LB
Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
[TBL] [Abstract][Full Text] [Related]
5. Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma.
Tao QF; Yuan SX; Yang F; Yang S; Yang Y; Yuan JH; Wang ZG; Xu QG; Lin KY; Cai J; Yu J; Huang WL; Teng XL; Zhou CC; Wang F; Sun SH; Zhou WP
Mol Cancer; 2015 Sep; 14():170. PubMed ID: 26376879
[TBL] [Abstract][Full Text] [Related]
6. Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.
Saito Y; Takasawa A; Takasawa K; Aoyama T; Akimoto T; Ota M; Magara K; Murata M; Hirohashi Y; Hasegawa T; Sawada N; Saito T; Osanai M
Cancer Sci; 2020 Aug; 111(8):3071-3081. PubMed ID: 32530543
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.
Peng SY; Lai PL; Pan HW; Hsiao LP; Hsu HC
Oncol Rep; 2008 Apr; 19(4):1045-53. PubMed ID: 18357395
[TBL] [Abstract][Full Text] [Related]
8. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
Kawai K; Uemura M; Munakata K; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
[TBL] [Abstract][Full Text] [Related]
9. Aldolase B impairs DNA mismatch repair and induces apoptosis in colon adenocarcinoma.
Lian J; Xia L; Chen Y; Zheng J; Ma K; Luo L; Ye F
Pathol Res Pract; 2019 Nov; 215(11):152597. PubMed ID: 31564566
[TBL] [Abstract][Full Text] [Related]
10. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
11. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
[TBL] [Abstract][Full Text] [Related]
12. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
[TBL] [Abstract][Full Text] [Related]
13. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
[TBL] [Abstract][Full Text] [Related]
14. Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
Mashita N; Yamada S; Nakayama G; Tanaka C; Iwata N; Kanda M; Kobayashi D; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
J Surg Oncol; 2014 Nov; 110(6):745-51. PubMed ID: 24975268
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
17. [Role of CTHRC1 in proliferation, migration and invasion of human colorectal cancer cells].
Yan L; Ye GT; Shen Z; Zhu X; Liu H; Li G
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):767-71, 776. PubMed ID: 26018280
[TBL] [Abstract][Full Text] [Related]
18. PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α-Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer.
Fu D; He C; Wei J; Zhang Z; Luo Y; Tan H; Ren C
Cell Physiol Biochem; 2018; 51(5):2434-2444. PubMed ID: 30537744
[TBL] [Abstract][Full Text] [Related]
19. h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases.
Hashimoto M; Kobayashi T; Tashiro H; Arihiro K; Kikuchi A; Ohdan H
Int J Cancer; 2016 Aug; 139(4):812-23. PubMed ID: 27037526
[TBL] [Abstract][Full Text] [Related]
20. Alpha B-crystallin promotes the invasion and metastasis of colorectal cancer via epithelial-mesenchymal transition.
Shi C; Yang X; Bu X; Hou N; Chen P
Biochem Biophys Res Commun; 2017 Aug; 489(4):369-374. PubMed ID: 28506831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
